Taro-Sodium Fusidate · DIN 02565587 · 2% · Oint
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Taro-Sodium Fusidate · DIN 02565587
Manufacturer: Taro Pharmaceuticals Inc.; listing date 2026-07-31
Health Canada: Marketed since 2026-06-11 · brand TARO-SODIUM FUSIDATE · ATC D06AX01 FUSIDIC ACID · form Ointment · route Topical · ingredients FUSIDATE SODIUM 2 %/W/W · company Taro pharmaceuticals inc · schedule Prescription
Taro-Sodium Fusidate: Formulary list price $0.84 per unit (the source does not state the unit; exact figure $0.8402). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02565587)
Source record
DIN 02565587: Taro-Sodium Fusidate
Raw flags: sec3=Y
Item: 840404007; group id 815; item number 1994; lccId None; manufacturer id TAR
Source form: Oint; strength: 2%
Recorded listing: General benefit
Source prices (unrounded): $0.8402; ministry $0.8402
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02565587
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=106817
Interchangeable products
Fucidin · DIN 00586676 · $0.8402
Shortage status: not checked (no credentials)